NEONATUS operates as an independent brand with complete ownership of its technology, quality systems, and clinical partnerships. Governance is not a bureaucratic formality—it is the disciplined framework that ensures every strategic decision, from product specification to regulatory submission, serves one fixed and immutable reference point: patient safety in the perinatal period.

Since inception, we have maintained a lean but rigorous governance structure. Shareholders appoint a Board of Directors responsible for strategic oversight. The Board integrates expertise in neonatology, obstetrics, paediatric intensive care, biomedical engineering, and global regulatory affairs—ensuring that product decisions are grounded in clinical reality rather than commercial convenience.

Specialised committees operate within the Board in proportion to the company’s scale:

• Audit Committee – oversees financial reporting, internal controls, and external audits. Financial integrity underpins clinical integrity.
• Nomination Committee – ensures the right balance of clinical and technical skills on the Board, identifying members who understand the unique pressures of perinatal and neonatal care.
• Compensation Committee – aligns executive rewards with long‑term value creation, measured by system uptime, clinical satisfaction, and documented improvements in patient outcomes.

The Board appoints executive officers to execute the strategic vision. Supporting them are internal groups, including a Neonatal Safety and Technology Committee, which reviews device performance, alarm accuracy, calibration drift, and adverse event reports, and a Risk and Regulatory Panel, which manages regulatory changes, supplier audits, and field safety corrections. An independent Internal Audit team reports directly to the Audit Committee.

Based in Shenzhen, NEONATUS applies these governance principles across all markets. A lean structure does not weaken governance; it makes every decision visible, every risk owned, and every leader accessible. Governance is not a diagram—it is a commitment to the families waiting outside the NICU, the nurses adjusting the ventilator, the doctors interpreting the bilirubin trend, and the administrators who must balance budgets against clinical need.